• Home
  • NEW DAY MEDICINE
  • 10 (48) 2022
  • 9 -10 (48) 2022 — D.M. Mamazhanova., F.I. Shukurov — FEATURES OF THE HEMOSTASIS SYSTEM IN PREGNANT WOMEN VACCINATED AGAINST COVID-19

9 -10 (48) 2022 — D.M. Mamazhanova., F.I. Shukurov — FEATURES OF THE HEMOSTASIS SYSTEM IN PREGNANT WOMEN VACCINATED AGAINST COVID-19

FEATURES OF THE HEMOSTASIS SYSTEM IN PREGNANT WOMEN VACCINATED AGAINST COVID-19

D.M. Mamazhanova., Tashkent Medical Academy

F.I. ShukurovTashkent Medical Academy

Resume

Objective: to study the features of the hemostasis system in pregnant women vaccinated against COVID-19.

Material and methods. 120 pregnant women vaccinated against COVID-19 were included in the study, they were divided into 2 groups according to the period of vaccination: group 1 – 60 women vaccinated in the second trimester of pregnancy, group 2 – 60 women vaccinated in the third trimester of pregnancy. The comparison group consisted of 30 pregnant women who refused vaccination for various reasons. All vaccinated pregnant women were analyzed for indicators describing the hemostasis system.

Results. In women vaccinated in the third trimester of pregnancy, compared to women vaccinated in the second trimester of pregnancy, on the 1st day after vaccination, a slightly higher level of indicators of the hemostasis system was found, including APTT 36.2±0.17sec and 30.6±0.24sec, fibrinogen content-6 ,5±0.14 g/l and 5.3±1.16 g/l, D-dimer – 3.1±0.14 μg/ml and 1.4±0.14 g/l, as well as the amount of platelets in the groups it decreased to 360.0±0.14 109/l and 358.0±0.27 109/l, respectively (p<0.001). However, these changes were determined at the level of normal indicators by 3 days after vaccination.

Conclusion. In the post-vaccination period, the indicators of the hemostasis system increased by 1.2 times compared to the 1st day, 1.0 times compared to the 2nd day, and 1.5 times compared to the 3rd day of the post-vaccination period in women vaccinated in the third trimester of pregnancy compared to women vaccinated in the second trimester of pregnancy and after vaccination, it was found that it decreased by 1 times according to the number of days. However, these changes did not exceed the level of standard indicators, which indicates that the vaccine Gam-Kovid-Vak used in vaccination did not have an adverse effect on the hemostasis system.

Key words: pregnancy, COVID-19, hemostasis system, vaccination, Gam-Kovid-Vak,

First page

47

Last page

51

For citation:D.M. Mamazhanova., F.I. Shukurov FEATURES OF THE HEMOSTASIS SYSTEM IN PREGNANT WOMEN VACCINATED AGAINST COVID-19 //New Day in Medicine 10(48)2022 47-51https://clck.ru/32RHpB

LIST OF REFERENCES:

  1. Адамян Л.В., Азнаурова Я.Б., Филиппов О.С. COVID-19 и женское здорове (обзор литературы) // Проблемы репродукции. 2020. Т.26, №2. С.6–17.
  2. Брико Н.И., Каграманян И.Н., Никифоров В.В., и др. Пандемия COVID-19. Меры борбы с ее распространением в Российской  Федерaции // Эпидемиология  и  вакцинопрофилактика.2020. Т. 19, № 2. С. 4–12.
  3. Временное клиническое руководство по ведению CОВИД-19 при беременности, родах и послеродовом периоде //Ташкент – 2020г. С.-31.
  4. Шифман Е. М., Иоскович А. М., Роненсон А. М., Куликов А. В. Обзор рекомендatsiй по ведению беременных с CОВИД-19: что должен знат акушерский анестезиолог // Вестник акушерской анестезиологии. – 2020. – №3. – С. 5–15.
  5. Щелканов М. Ю., Колобухина Л. В., Лвов Д. К. Коронавирусы человека (Нидовиралес, Cоронавиридае): возросший уровен эпидемической опасности // Лечащий Врач. – 2013. – №10. – С. 49–54.
  6. Alfaraj S. H., Al-Tawfiq J. A., Memish Z. A. Middle East respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: report of two cases and review of the literature // J. Microbiol. Immunol. Infect. — 2019. – Vol. 52. – №3. – P. 501–503.
  7. Mamajonova D.M., Shukurov F.I. Clinical and laboratory features of vaccination against COVID-19 in pregnant women // Journal of Educational Scientific Medicine,№2, 2022.S.32-37.
  8. Ciavarella A, Erra R, Abbattista M, Iurlaro E, Boscolo-Anzoletti M, Ossola MW, et al. Hemostasis in pregnant women with COVID-19. // Int J Gynaecol Obstet. 2021 Feb;152(2):268-9.
  9. Peyvandi F, Artoni A, Novembrino C, Aliberti S, Panigada M, Boscarino M, et  al.  Hemostatic  alterations  in  COVID-19.  // Haematologica.  2020  Aug  27.
  10. Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. // J Thromb Haemost. 2020 May;18(5):1023-6.

file

download